Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Publications section now states that entries are automatically filled from PubMed and updates the revision label to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-26T13:52:03.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The funding status notice was removed from the page; this does not affect the study details on the ClinicalTrials.gov record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-19T08:34:22.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The new page shows minor formatting updates and a refreshed last update timestamp. Core study content such as design, eligibility criteria, treatment arms, and primary/secondary outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:16:57.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Update propagates more current date markers and an explicit estimated last-update line, replacing older timestamps.
    Difference
    0.3%
    Check dated 2025-10-21T01:29:56.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Core content now includes an important government-operating status notice and a version upgrade to v3.2.0, replacing v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T15:54:13.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.0%
    Check dated 2025-09-29T09:51:23.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.